Keyphrases
Amyotrophic Lateral Sclerosis
100%
Lymphocyte Infusion
100%
First-in-human Study
100%
Treg
100%
Treg Lymphocytes
100%
Suppressive Function
41%
Disease Progression
25%
Progression Rate
16%
Disease Stage
16%
Clinical Trials
8%
Adverse Effects
8%
Clinical Status
8%
Potential Gains
8%
Disease Onset
8%
Site of Disease
8%
Interleukin-2
8%
Family History
8%
Disease Rate
8%
Regulatory T
8%
Leukapheresis
8%
Safety Benefits
8%
Maximal Inspiratory Pressure
8%
Spearman Correlation Analysis
8%
Medicine and Dentistry
Infusion
100%
Amyotrophic Lateral Sclerosis
100%
Human Study
100%
Regulatory T Lymphocyte
100%
Diseases
50%
Disease Exacerbation
37%
Clinical Trial
12%
Adverse Effect
12%
Ex Vivo
12%
Family History
12%
Interleukin 2
12%
Leukapheresis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Amyotrophic Lateral Sclerosis
100%
Human Study
100%
Diseases
66%
Disease Exacerbation
50%
Clinical Trial
16%
Interleukin 2
16%
Nursing and Health Professions
Infusion
100%
Amyotrophic Lateral Sclerosis
100%
Diseases
50%
Disease Exacerbation
37%
Interleukin 2
12%
Family History
12%
Leukapheresis
12%
Maximal Inspiratory Pressure
12%
Neuroscience
T Cell
100%
Amyotrophic Lateral Sclerosis
100%
Adverse Effect
16%
Interleukin 2
16%